Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

I appreciate that you're trying to help and I'm humbled by your knowledge of the science.

"Lots of reasons why trials can take longer than anticipated -- ~80% of all trials fail to meet enrollment timelines."
I was asking about specific reasons and about a specific trial, but that's an interesting statistic. Obviously a lot of people do an awfully lousy job of estimating enrollment timelines.


"competing studies at sites was cited I recall"
I didn't remember a competing sites issue coming up in a company explanation for the pace of recruiting for OM testing...maybe I missed it.

".... waiting to increase trial sites to conserve capital until research provided additional support to the potential of the anti-inflammatory and immunomodulatory properties of the drug candidate."
I remember financing to be the explanation for the decision to hold off on the ABSSSI P3, but I see it was used as an explanation for OM timing as well.



I provided the list of exclusions thinking that one or more of those might specifically account for some of the delay. The universe of people getting the treatment that causes the problem is relatively huge so I thought perhaps the exclusions may have played into the actual available recruits.